Press release
Investigation announced for Long-Term Investors in Organogenesis Holdings Inc. (NASDAQ: ORGO)
An investigation on behalf of current long term investors in Organogenesis Holdings Inc. (NASDAQ: ORGO) shares.
Investors who are current long term investors in Organogenesis Holdings Inc. (NASDAQ: ORGO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ORGO stocks follows a lawsuit filed against Organogenesis Holdings Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ORGO stocks, concerns whether certain Organogenesis Holdings Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose that Organogenesis improperly billed the federal government for its Affinity and PuraPly XT products by, among other things, setting the price for those products multiple times higher than similar products, that the Company improperly induced doctors to use its Affinity and PuraPly XT products through lucrative reimbursements, that as a result of all the foregoing, the Company's revenue and profits derived from its Affinity and PuraPly XT products were at least in substantial part unsustainable, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Organogenesis Holdings Inc. (NASDAQ: ORGO) have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in Organogenesis Holdings Inc. (NASDAQ: ORGO) here
News-ID: 2601570 • Views: …
More Releases from Shareholders Foundation
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
More Releases for Organogenesis
Regenerative Medicine Platforms Market Is Going to Boom |• Acelity • Organog …
Worldwide Market Reports (WMR) has released a new, in-depth research study on the Regenerative Medicine Platforms Market, projected to witness strong and sustained growth in the coming years. The report delivers a fact-based, strategic analysis of the global market landscape using a robust research framework that integrates market sizing, validated data modeling, and insights drawn from multiple authoritative sources.
This study is designed to support executive decision-making, strategic planning, and investment…
Skin Substitutes Market Is Going to Boom |• Acelity • Organogenesis
According to Worldwide Market Reports (WMR) highlights that the "Skin Substitutes Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends, technological…
Scaffold Technology Market Is Going to Boom |• Organogenesis • Acelity • M …
According to Worldwide Market Reports (WMR) highlights that the "Scaffold Technology Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends, technological…
Skin Grafts Market Is Booming Worldwide 2025-2032 | Organogenesis, Integra LifeS …
Global skin grafts market is estimated to be valued at USD 1.12 Bn in 2025 and is expected to reach USD 1.85 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
According to the latest research by Coherent Market Insights, the Skin Grafts Market is projected to witness significant growth from 2025 to 2032. This report provides a detailed outlook on market trends, drivers,…
Amniotic Product Market Massive Growth opportunity Ahead | MiMedx, Smith & Nephe …
Exactitude Consultancy has recently released a comprehensive research report titled "Amniotic Product Market Insights, Extending to 2032." This publication spans over 110+ pages and offers an engaging presentation with visually appealing tables and charts that are self-explanatory.
The extensive Amniotic Product market report conducts market research to assist clients in predicting investment in a growing market, expanding their market share, or achieving success with a new product. Various insights about the…
Wound Care Biologics Market Analysis Report 2021 | Smith & Nephew, Organogenesis
The Latest research study released by CMI "Global Wound Care Biologics Market" with 360+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. This report likewise contemplates the worldwide Wound Care Biologics market…
